Nuvation Bio Inc.
Nuvation Bio Inc.
Share · US67080N1191 · NUVB-WT (XNYS)
Overview
No Price
16.09.2025 14:51
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Current Prices from Nuvation Bio Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
NUVB-WT
USD
16.09.2025 14:51
0,18 USD
-0,004 USD
-1,91 %
ESG Risk Rating
B Good
Share Float & Liquidity
Free Float 66,65 %
Shares Float 2,53 B
Shares Outstanding 3,79 B
Company Profile for Nuvation Bio Inc. Share
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Company Data

Name Nuvation Bio Inc.
Company Nuvation Bio Inc.
Symbol NUVB-WT
Website http://www.nuvationbio.com
Primary Exchange XNYS NYSE
ISIN US67080N1191
Asset Class Share
Sector Healthcare
Industry Biotechnology
Market Capitalization 715 Mio
Country United States of America
Currency USD
Employees 0,2 T
Address , New York City

Ticker Symbols

Name Symbol
NYSE NUVB-WT
More Shares
Investors who hold Nuvation Bio Inc. also have the following shares in their portfolio:
ONTARIO PROV. 16/26
ONTARIO PROV. 16/26 Bond
RENAU.UNSP.ARD 1/5 EO-,20
RENAU.UNSP.ARD 1/5 EO-,20 Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025